Pediatric Blood and Cancer : Impact Factor & More
eISSN: 1545-5017pISSN: 1545-5009
Share this on:
Key Metrics
CiteScore 
4.8
Impact Factor
< 5
SJR
Q2Oncology
SNIP
1.29
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Pediatric Blood and Cancer
Pediatric Blood and Cancer Journal Specifications
| Overview | |
| Publisher | WILEY |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 2004 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Pediatric Blood and Cancer ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Pediatric Blood and Cancer
Vital Voices: Patient/Family Perspectives to Improve Treatment for Pediatric B-ALL.
- 1 Jan 2026
- Pediatric blood & cancer
CD4+ Memory Stem-Cell T Lymphocyte Frequency Is a Marker of Alloreactivity and a Predictor of Long-Term Morbidity and Mortality After Hematopoietic Cell Transplantation.
- 1 Jan 2026
- Pediatric blood & cancer
Molecularly Informed Combination Therapy for BRAF-KIAA1549 Fusion-Positive Pilocytic Astrocytoma in a Resource-Limited Setting.
- 1 Jan 2026
- Pediatric blood & cancer
A Phase I Trial of Nab-Paclitaxel in Combination With Gemcitabine for Relapsed/Refractory Pediatric Solid Tumors.
- 1 Jan 2026
- Pediatric blood & cancer
Breast Findings in Females With Beckwith-Wiedemann Syndrome.
- 1 Jan 2026
- Pediatric blood & cancer
Trust, Transparency, and Acceptability of Artificial Intelligence-Powered Communication Tools in Cancer: Focus Groups With Parents, Adolescents, and Young Adults.
- 1 Jan 2026
- Pediatric blood & cancer
Vital Voices: Patient/Family Perspectives to Improve Treatment for Pediatric B-ALL.
- 1 Jan 2026
- Pediatric blood & cancer
CD4+ Memory Stem-Cell T Lymphocyte Frequency Is a Marker of Alloreactivity and a Predictor of Long-Term Morbidity and Mortality After Hematopoietic Cell Transplantation.
- 1 Jan 2026
- Pediatric blood & cancer
Molecularly Informed Combination Therapy for BRAF-KIAA1549 Fusion-Positive Pilocytic Astrocytoma in a Resource-Limited Setting.
- 1 Jan 2026
- Pediatric blood & cancer
A Phase I Trial of Nab-Paclitaxel in Combination With Gemcitabine for Relapsed/Refractory Pediatric Solid Tumors.
- 1 Jan 2026
- Pediatric blood & cancer
Breast Findings in Females With Beckwith-Wiedemann Syndrome.
- 1 Jan 2026
- Pediatric blood & cancer
Trust, Transparency, and Acceptability of Artificial Intelligence-Powered Communication Tools in Cancer: Focus Groups With Parents, Adolescents, and Young Adults.
- 1 Jan 2026
- Pediatric blood & cancer
FAQs on Pediatric Blood and Cancer
How long has Pediatric Blood and Cancer been actively publishing? 
What is the publishing frequency of Pediatric Blood and Cancer?
How many articles did Pediatric Blood and Cancer publish last year?
What is the eISSN & pISSN for Pediatric Blood and Cancer?
What is Citescore for Pediatric Blood and Cancer?
What is SNIP score for Pediatric Blood and Cancer?
What is the SJR for Pediatric Blood and Cancer?
Who is the publisher of Pediatric Blood and Cancer?
